Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
April 14, 2020
Provisional Patent Application Filed for High Sensitivity COVID-19 Diagnostic Assay
March 24, 2020
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20, 2020
Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection
March 19, 2020
Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models
March 18, 2020
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
March 2, 2020
Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products
February 20, 2020
Get Social